Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Beitsch

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Surgical Research|October 24, 2007
Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasisRyaz B Chagpar, Merrick I Ross, Douglas S Reintgen, et al.
Annals of Surgical Oncology|December 8, 2009
Factors associated with false-negative sentinel lymph node biopsy in melanoma patientsCharles R Scoggins, Robert C G Martin, Merrick I Ross, et al.
Annals of Surgery|April 25, 2006
Gender-related differences in outcome for melanoma patientsCharles R Scoggins, Merrick I Ross, Douglas S Reintgen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node BiopsyKelly M McMasters, Michael E Egger, Michael J Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Circulating tumor cells in patients with breast cancer dormancySongdong Meng, Debasish Tripathy, Eugene P Frenkel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanomaCharles R Scoggins, Merrick I Ross, Douglas S Reintgen, et al.
American Journal of Clinical Oncology|June 19, 2012
Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 yearRakesh R Patel, Peter D Beitsch, Timothy D Nichols, et al.
Surgical Oncology|November 27, 2022
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancerJames V Pellicane, Peter D Beitsch, David T Rock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2018
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?Peter D Beitsch, Pat W Whitworth, Kevin Hughes, et al.
JCO Precision Oncology|September 15, 2022
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant TherapyPat W Whitworth, Peter D Beitsch, Mary K Murray, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Surgical Research|October 24, 2007
Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasisRyaz B Chagpar, Merrick I Ross, Douglas S Reintgen, et al.
Annals of Surgical Oncology|December 8, 2009
Factors associated with false-negative sentinel lymph node biopsy in melanoma patientsCharles R Scoggins, Robert C G Martin, Merrick I Ross, et al.
Annals of Surgery|April 25, 2006
Gender-related differences in outcome for melanoma patientsCharles R Scoggins, Merrick I Ross, Douglas S Reintgen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node BiopsyKelly M McMasters, Michael E Egger, Michael J Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Circulating tumor cells in patients with breast cancer dormancySongdong Meng, Debasish Tripathy, Eugene P Frenkel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanomaCharles R Scoggins, Merrick I Ross, Douglas S Reintgen, et al.
American Journal of Clinical Oncology|June 19, 2012
Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 yearRakesh R Patel, Peter D Beitsch, Timothy D Nichols, et al.
Surgical Oncology|November 27, 2022
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancerJames V Pellicane, Peter D Beitsch, David T Rock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2018
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?Peter D Beitsch, Pat W Whitworth, Kevin Hughes, et al.
JCO Precision Oncology|September 15, 2022
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant TherapyPat W Whitworth, Peter D Beitsch, Mary K Murray, et al.
Pageof 6